Best Practices for Orange Book Listings
An article authored by Jonathan Roses titled “Best Practices for Orange Book Listings” was published in The Pharma Letter as an “Expert View.” In this article, Jon provides insights into how to succes...
Jonathan Roses counsels an array of clients, including life sciences companies focused on the areas of small molecule pharmaceuticals, pharmaceutical formulations, medical devices and surgical methods.
View profileAn article authored by Jonathan Roses titled “Best Practices for Orange Book Listings” was published in The Pharma Letter as an “Expert View.” In this article, Jon provides insights into how to succes...
What is top of mind right now for in-house life sciences IP counsel? I recently attended the Life Sciences Patent Network (LSPN) North America conference in Boston, and was lucky enough to moderate a ...
Jonathan Roses was the lead author on behalf of the Boston Intellectual Property Law Association (BIPLA) of a January 2023 Response to USPTO Request for Comments regarding proposed initiatives to ensu...
Jonathan Roses co-authored on behalf of the Boston Intellectual Property Law Association (BIPLA) a January 2023 Response to USPTO Request for Comments regarding proposals to expand the criteria for ad...
Jonathan Roses co-authored on behalf of the Boston Patent Law Association (BPLA) a July 2022 Response to USPTO Request for Comments regarding issues associated with, and options for designing, a small...
Jonathan Roses co-authored on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice Committee an October 2021 Response to USPTO Request for Information on the current state of ...
Jonathan Roses co-authored on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice Committee a May 2021 Response to USPTO Request for Comments on proposed updates to the USPTO...
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association’s (BPLA’s) Patent Office Practice and Licensing Committees of an April 2021 Response to a Notice of Proposed Rulemakin...
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice and ad hoc Diversity & Inclusion Committees of a February 2021 Response to USPTO...
An article written by Jonathan Roses and Alexander Lee, associate at Hoffmann Eitle, titled "Doctrine of Equivalents in US and European Patent Law" was published in The Pharma Letter. Read more (subsc...
An article written by Jonathan Roses and Matthew Birkett, partner at Hoffmann Eitle, titled "Salt and Solid Form Issues in US and European Patents" was published in The Pharma Letter. Read more (subsc...
An article written by Jonathan Roses and Matthew Birkett, partner at Hoffmann Eitle, titled "Double Patenting in the USA and Europe" was published in The Pharma Letter. Read more (subscription require...